Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA Read more →
Innate ends work on NK cell engager in phase 1/2 trial as part of ongoing pipeline refocus Read more →
FDA approves Denali's Hunter syndrome drug, handing rare disease community a win Read more →
« All Events
February 4, 2025 @ 5:30 pm
An agenda-free networking evening which provides opportunities for key people from companies working in or with the life sciences sector to network and socialise with their peers in an informal setting over a drink or two.